Jobs / United States / Abbott Laboratories
Global Head of Market Access
Abbott Laboratories · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 73 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 28 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Abbott Laboratories paid sponsored hires in similar roles3 certified filings for “Technical Lead, Global Service” (Bioengineers and Biomedical Engineers) in TX: $113k–$140k, median $125k. Most were filed at wage level IV (67%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Abbott Laboratories
The US Department of Labor certified 73 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 28 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Abbott Laboratories →
About the role
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries. JOB DESCRIPTION: WORKING AT ABBOTT: At Abbott, you can do work that matters, grow, and learn, care for yourself and family, be your true self and live a full life. You’ll also have access to: • Career development with an international company where you can grow the career you dream of. • Employees can qualify for free medical coverage in our Health Investment Plan (HIP) PPO medical plan in the next calendar year. • An excellent retirement savings plan with high employer contribution • Tuition reimbursement, the Freedom 2 Save student debt program and FreeU education benefit - an affordable and convenient path to getting a bachelor’s degree • A company recognized as a great place to work in dozens of countries around the world and named one of the most admired companies in the world by Fortune. • A company that is recognized as one of the best big companies to work for as well as a best place to work for diversity, working mothers, female executives, and scientists. THE OPPORTUNITY: The Global Head of Market Access is the senior enterprise leader responsible for creating and leading a world-class Market Access Center of Excellence that serves as a growth engine for the Abbott Point-of-Care business. The role is accountable for shaping standards of care, influencing clinical pathways, generating economic evidence, securing reimbursement, enabling guideline adoption, and accelerating commercial adoption of both existing and future diagnostic innovations. The position leads a globally integrated function spanning Policy & Advocacy, Payer and Reimbursement Strategy, Health Economics and Outcomes Research (HEOR), and Clinical Marketing. The role is responsible for ensuring that market access is embedded across the product lifecycle from early development through launch and lifecycle optimization, with particular focus on accelerating global growth of high-sensitivity Troponin-I (hs‑TnI), Traumatic Brain Injury (TBI) diagnostics, and future OEM new product introductions. Success is measured by adoption, utilization, reimbursement, and revenue impact. WHAT YOU’LL WORK ON: • Develop and execute the global market access strategy aligned to OEM growth objectives • Lead Policy & Advocacy, HEOR, Payer & Reimbursement, and Clinical Marketing functions (2-3 direct reports initially) • Shape clinical guidelines, standards of care, reimbursement frameworks, and policy environments • Establish global payer engagement and reimbursement pathway strategies. • Develop pricing and value strategies in partnership with Marketing, including willingness-to-pay assessments, payer value narratives, pricing corridors, and support for Core Value Dossiers (CVDs) • Oversee design and execution of HEOR, real-world evidence, budget impact, and cost-effectiveness programs • Build global value dossiers, HTA submissions, economic models, and value communication materials • Accelerate adoption of hs‑TnI and TBI solutions through clinical pathway transformation • Lead access strategy for all future NPIs beginning in product development • Create launch excellence processes and market access readiness requirements • Build relationships with KOLs, clinical societies, HTA bodies, payers, government stakeholders, and advocacy groups • Translate evidence into provider protocols, economic value propositions, and adoption programs • Partner with Commercial, Medical Affairs, R&D, Regulatory, Government Affairs a